CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Nirali N. Shah, Pamela L. Wolters et al.|Blood|2022Cited by 179
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategiesAlexandra Dreyzin, Nirali N. Shah, Anne Marijn Kramer et al.|Cytotherapy|2025Cited by 1